News About: Pharm. Industry


Ilyang Pharmaceutical’s ‘Supect’ effectively inhibits Parkinson’s disease progress

The preclinical and efficacy result on the Ilyang Pharmaceutical’s(President Dong-Yeon Kim) chronic myelocytic leukemia treatment ‘Supect(generic name: radotinib)’ for Parkinson’s disease(PD) was announced at the ‘Ame...

Humira takes over ‘uveitis’ as well with versatility

‘Humira(generic name: adalimumab),’ the most well-known TNF(tumor necrosis factor)-α inhibitor and a chronic immune disorder treatment having 14 Korean indications in Korea, has attracted attention of the industry as ...

Kwang Dong Pharmaceutical signs contract sales agreement of Jeju Samdasoo

Kwang Dong Pharmaceutical(CEO Sung-Won Choi) announced on the 9th that it signed a contract sales agreement of Jeju Samdasoo retail products with the Jeju Province Development Co.(President Kyung-Soo Oh) at Sheraton S...

Big5 pharmas, Yuhan and Daewoong top in sales and profitability respectively

While the ‘Big5’ pharmaceutical companies’ business performance is evaluated excellent this year, Yuan Corporation and Daewoong Pharmaceutical was analyzed to have a remarkable business performance. Yakup Shinmoon(ww...

Pharmaceutical companies’ poor quality control on their imported medicines

Multinational pharmaceutical companies were criticized for poorly managing their imported medicines. According to the Ministry of Food and Drug Safety(MFDS), there has been an increasing number of multinational pharm...

Samsung Bioepis acquires product approval of ‘Samfenet,’ Herceptin biosimilar

‘SB3(product name: Samfenet, generic name: trastuzumab),’ a Samsung Bioepis’ cancer therapy biosimilar, acquire product approval from the Ministry of Food and Drug Safety on the 8th. Samfenet is a biosimilar of ‘Herc...

Pharma industry accelerate rebate eradication process well-prepared plans

The pharmaceutical companies’ process to establish ethical management will be accelerated by eradicating illegal rebates. The Korea Pharmaceutical and Bio-Pharma Manufacturers Association held a Chairmen’s meeting on...

9 companies including Yuhan, Green Cross and Hanmi Pharm, first to adopt ‘ISO 37001’

In order to keep the pharmaceutical distribution order transparent, the Korean pharmaceutical industry has accelerated in the self-purification process and reforming its own system. A process has been scheduled to ad...

No. of employees in pharma field was approx. 64 thousand, increased by 4.8% year-on-year

The number of employees in the pharmaceutical field was about 64 thousand increased by 4.8% year-on-year in the 1st half of the year, but it was the lowest increase among other fields in the health care industry. The...

AZ, “We do not consider withdrawing Tagrisso from getting health insurance benefits”

While patient associations are pressing the National Health Insurance Service(NHIS) and AstraZeneca to conclude the drug price negotiation for the company’s non-small cell lung cancer treatment, Tagrisso(generic name:...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.